Vitamin D Deficiency Is Associated with Increased Mortality and Seizure Risk After Nontraumatic Subarachnoid Hemorrhage: A Propensity Score-Matched Cohort Study
Brain Sciences · 08.05.2026 · 16 (5) · 506
DOI: 10.3390/brainsci16050506 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Brain Sciences, online erschienen am 08.05.2026. Verfasst von Saketh Amasa und 4 weiteren Autor:innen. Beteiligte Einrichtung: John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX 77550, USA. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Subarachnoid hemorrhage (SAH) is associated with high morbidity and mortality despite advances in neurocritical care. Vitamin D plays a role in immune modulation, endothelial function, and neuroprotection; however, its impact on outcomes following SAH remains poorly defined. We evaluated the association between low vitamin D status and clinical outcomes in patients with nontraumatic SAH.
Methods
We conducted a retrospective propensity score-matched cohort study using the TriNetX Research Network database. Adult patients with nontraumatic SAH and at least one recorded serum 25-hydroxyvitamin D level obtained within 3 months on or before diagnosis were included. The low vitamin D cohort was defined as 0–20 ng/mL, and the comparator cohort as 20–40 ng/mL. Cohorts were matched 1:1 using propensity scores adjusted for demographic and clinical covariates, including chronic kidney disease, liver disease, osteoporosis, and intestinal malabsorption. The primary outcome was 30-day all-cause mortality. Secondary outcomes included seizures, hydrocephalus, cerebral edema, and external ventricular drain placement.
Results
After matching, 2314 patients were included in each cohort. Thirty-day mortality occurred in 9.3% of patients in the low vitamin D cohort and 7.6% of patients in the comparator cohort (hazard ratio [HR] 1.229; 95% CI, 1.006–1.503; p = 0.043). Seizures were more frequent in the low vitamin D cohort (8.6% vs. 6.9%; odds ratio [OR] 1.274; 95% CI, 1.026–1.581; p = 0.028). Hydrocephalus was also more common among patients with low vitamin D (5.1% vs. 3.9%; OR 1.328; 95% CI, 1.003–1.758; p = 0.047). No significant differences were observed in cerebral edema or external ventricular drain placement.
Conclusions
Low vitamin D status was associated with increased short-term mortality, seizure incidence, and hydrocephalus following nontraumatic SAH. These findings suggest that vitamin D status may represent a potential prognostic biomarker warranting prospective investigation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX 77550, USA.
- Texas A&M Vasisht College of Medicine, Texas A&M University, College Station, TX 77843, USA.
- Department of Public Health, University of Texas at Austin, Austin, TX 78712, USA.
- School of Medicine, Boston University, Boston, MA 02118, USA.
ORCID-Profile: Saketh Amasa, Parsa Radfar, Asha Collier
Zitieren
APA
Amasa, S., Radfar, P., Adams, A., Collier, A., & Buendia, J. (2026). Vitamin D Deficiency Is Associated with Increased Mortality and Seizure Risk After Nontraumatic Subarachnoid Hemorrhage: A Propensity Score-Matched Cohort Study. Brain Sciences, 16(5), 506. https://doi.org/10.3390/brainsci16050506
Vancouver
Amasa S, Radfar P, Adams A, Collier A, Buendia J. Vitamin D Deficiency Is Associated with Increased Mortality and Seizure Risk After Nontraumatic Subarachnoid Hemorrhage: A Propensity Score-Matched Cohort Study. Brain Sciences. 2026;16(5):506. doi:10.3390/brainsci16050506
BibTeX
@article{Amasa2026,
author = {Amasa, Saketh and Radfar, Parsa and Adams, Aiyana and Collier, Asha and Buendia, Justin},
title = {Vitamin D Deficiency Is Associated with Increased Mortality and Seizure Risk After Nontraumatic Subarachnoid Hemorrhage: A Propensity Score-Matched Cohort Study},
journal = {Brain Sciences},
year = {2026},
volume = {16},
number = {5},
pages = {506},
doi = {10.3390/brainsci16050506}
}
EUVIMED